CTO and Co-Founder of “Cannabics Pharmaceuticals Inc.”, Eyal Ballan says “gastrointestinal cancers are among the most widespread causes of cancer-related deaths worldwide”. With very few treatment methods of things like stomach cancer, colon, cancer, esophageal cancer, and gallbladder cancer, its easy to see why doctors and pharmaceutical specialists would jump on the opportunity to research a possible natural cure / course of treatment.
CBG deactivates the body’s CB2 receptor, which is predominately associated with immune system response. This improves oxidative stress responses, and reduces cell growth in colorectal cancer cells. A recent study investigated the potency of both CBG and CBC (cannabichromene) against gastrointestinal cancer cells. Both cannabinoids were shown to induce significantly higher rates of caner cell death compared to other cannabinoids like THC and CBD. Scientists are currently studying the synergistic efficiency of these cannabinoids to determine weather they work better together in a carefully concocted drug, or if they work best on their own.
Side effects of CBG are fairly similar to those of CBD, however they’re a whole lot more manageable than those of Chemo and other cancer treatments. CBG can make you tired/groggy, give you diarrhea, change your appetite, and change your weight. These side effects are often associated with large doses of CBG. Your body’s endocannabinoid system knows exactly what to do with cannabinoids, but when it has more than it needs, it tends to store them for later use. Some studies suggest that CBG is slightly different from CBD in that it has higher chances of producing unwanted side effects when taken in extraordinarily high doses. Therefore if you’re using CBG as a treatment, and you’re experiencing these side effects, it’s a good idea to lower your dose little by little until you’re no longer experiencing them.